| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 03/02/2006 | WO2005059093A3 P ef-tu expression units |
| 03/02/2006 | WO2005014781A3 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 03/02/2006 | WO2004092332A3 Sars virus polypeptides |
| 03/02/2006 | WO2004083379A3 Large volume ex vivo electroporation method |
| 03/02/2006 | WO2004078950A3 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS |
| 03/02/2006 | WO2003070902A3 Receptors and membrane-associated proteins |
| 03/01/2006 | EP1629107A2 Cyclodextrin affinity purification |
| 03/01/2006 | EP1629106A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 03/01/2006 | EP1629095A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 03/01/2006 | EP1629088A2 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 03/01/2006 | EP1629087A2 N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor |
| 03/01/2006 | EP1629086A2 POLYNUCLEOTIDES ENCODING NOVEL GUANYLATE BINDING PROTEINS (GBP'S) |
| 03/01/2006 | EP1629084A2 Modulation of c-reactive protein expression |
| 03/01/2006 | EP1629083A2 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests |
| 03/01/2006 | EP1628996A2 Imageable animal model of sars infection |
| 03/01/2006 | EP1628992A2 Methods of modulating metastasis and skeletal related events resulting from metastases |
| 03/01/2006 | EP1628953A2 Process for preparing reverse transcriptase inhibitors |
| 03/01/2006 | EP1628680A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/01/2006 | EP1628675A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 03/01/2006 | EP1628674A2 Protease inhibitors for coronaviruses and sars-cov and the use thereof |
| 03/01/2006 | EP1628668A2 1,1-disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibito rs |
| 03/01/2006 | EP1628535A2 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | EP0920498B1 Hamster ef-1alpha transcriptional regulatory dna |
| 02/28/2006 | US7005252 Serum free cultivation of primate embryonic stem cells |
| 02/23/2006 | WO2005052128A3 Mrna transfected antigen presenting cells |
| 02/23/2006 | WO2005049792A3 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
| 02/23/2006 | WO2005047485A3 Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
| 02/23/2006 | WO2005044997A3 Identification of novel targets for radio sensitization using a genomic-based radiation sensitivity classifier |
| 02/23/2006 | WO2005044976A3 Oligomeric compounds for use in gene modulation |
| 02/23/2006 | WO2005042700A3 Use of hedgehog pathway inhibitors in small-cell lung cancer |
| 02/23/2006 | WO2005030928A3 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 02/23/2006 | WO2005028631A3 A novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same |
| 02/23/2006 | WO2005003372A3 Mylks as modifiers of branching morphogenesis and methods of use |
| 02/23/2006 | WO2004108885A3 Fc chimeric proteins with anti-hiv drugs |
| 02/23/2006 | WO2003070889A3 Prostate specific genes and the use thereof in design or therapeutics |
| 02/23/2006 | US20060040384 Serum free cultivation of primate embryonic stem cells |
| 02/23/2006 | US20060040283 Methods of manipulating nucleic acids |
| 02/23/2006 | US20060039906 Humanized antibodies that sequester abeta peptide |
| 02/22/2006 | EP1627081A2 Use of jag2 expression in diagnosis of plasma cell disorders |
| 02/22/2006 | EP1627080A2 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 02/22/2006 | EP1627071A2 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 02/22/2006 | EP1627050A2 Variant humicola grisea cbh1.1 |
| 02/22/2006 | EP1627049A2 Novel trichoderma genes |
| 02/22/2006 | EP1627048A2 Compositions for down-regulation of ccr5 expression and methods of use therefor |
| 02/22/2006 | EP1627047A2 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid |
| 02/22/2006 | EP1627046A2 Domain-exchanged binding molecules, methods of use and methods of production |
| 02/22/2006 | EP1627045A2 Pyk2 crystal structure and uses |
| 02/22/2006 | EP1627044A2 Methods, systems and apparatus for identifying genetic differences in disease and drug response |
| 02/22/2006 | EP1626979A2 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 02/22/2006 | EP1626978A2 Polymerase-based protocols for the introductions of deletions and insertions |
| 02/22/2006 | EP1626718A2 Methods of treating ischemic related conditions |
| 02/22/2006 | EP1587869A4 Membrane active polymers |
| 02/22/2006 | CN1738910A Expression profiling based on histocultures |
| 02/22/2006 | CN1737121A Escherichia bacteria capable of generating l-amino acid and method for generating l-amino acid |
| 02/22/2006 | CN1737120A Escherichia bacteria capable of generating L-amino acid and method for generating L-amino acid |
| 02/22/2006 | CN1737119A Escherichia bacteria capable of generating l-amino acid and method for generating l-amino acid |
| 02/21/2006 | US7002006 reacting a nucleoside with a protecting reagent and activator to produce a regioselectively protected oligonucleoside; lutidine activator improves selectivity; for automatic synthesis of primers, probes and antiseisure agents |
| 02/16/2006 | WO2005049805A3 Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast |
| 02/16/2006 | WO2005047486A3 Biological production of tetradehydrolycopene |
| 02/16/2006 | WO2005038004A3 Method to product para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promter |
| 02/16/2006 | WO2005014791A3 Methods and compositions for targeted cleavage and recombination |
| 02/16/2006 | WO2005007830A3 Methods and compositions for diagnosis, staging and prognosis of prostate cancer |
| 02/16/2006 | WO2004101752A3 Compounds for treatment of inflammation, diabetes and related disorders |
| 02/16/2006 | WO2004097003A3 Multiply-primed amplification of nucleic acid sequences |
| 02/16/2006 | WO2004096992A3 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 02/16/2006 | WO2004078936A3 Methods for preventing gluconoylation of proteins |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060035377 Pathogen-resistant grape plants |
| 02/16/2006 | US20060035373 Stem cell libraries |
| 02/16/2006 | US20060035218 For in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments |
| 02/15/2006 | EP1626053A2 Method of alpha-selective glycosylation |
| 02/15/2006 | EP1625220A2 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 02/15/2006 | EP1625211A2 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/15/2006 | EP1625210A2 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 02/15/2006 | EP1625209A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 02/15/2006 | EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders |
| 02/15/2006 | EP1625203A2 Efficient haploid cell sorting for flow cytometer systems |
| 02/15/2006 | EP1625201A2 Production of carotenoids in microorganisms |
| 02/15/2006 | EP1625199A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 02/15/2006 | EP1625149A2 Method and carrier complexes for delivering molecules to cells |
| 02/15/2006 | EP1625142A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 02/15/2006 | EP1625141A2 Grp94-based compositions and methods of use thereof |
| 02/15/2006 | EP1624900A2 Methods for binding agents to beta-amyloid plaques |
| 02/15/2006 | EP1624891A2 Clotting factor-fc chimeric proteins to treat hemophilia |
| 02/15/2006 | EP1624876A2 Selective testicular 11beta-hsd inhibitors and methods of use thereof |
| 02/15/2006 | CN1735694A Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 02/15/2006 | CN1735338A Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 02/09/2006 | WO2005059106A3 Interferon alpha antibodies and their uses |
| 02/09/2006 | WO2005014794A3 Generation of low phytate plants by molecular disruption of inositol polyphosphate kinases |
| 02/09/2006 | WO2005000087A3 Gene products differentially expressed in cancerous colon cells and their methods of use ii |
| 02/09/2006 | WO2004050839A3 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 02/09/2006 | WO2003068923A3 Signal for packaging of influenza virus vectors |
| 02/09/2006 | US20060029940 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/08/2006 | EP1623227A2 Proteins, sensors, and methods of characterizing analytes using the same |
| 02/08/2006 | EP1623222A2 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 02/08/2006 | EP1623044A2 Methods for amplification of nucleic acid sequences using staggered ligation |
| 02/08/2006 | EP1623036A2 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2006 | EP1623018A2 Mptens as modifiers of the pten/igf pathway and methods of use |